Sphingolipids as Mediators of Inflammation and Novel Therapeutic Target in Inflammatory Bowel Disease

Medicine and Dentistry

• Serositis 100%
• Mediator 100%
• Inflammatory Bowel Disease 100%
• Sphingolipid 100%
• Sphingosine 1 Phosphate 66%
• Receptor 50%
• Gastrointestinal Disease 50%
• Therapeutic Procedure 33%
• Tumor Necrosis Factor 33%
• Colitis 33%
• Pathology 16%
• Host 16%
• Morbidity 16%
• Enzyme 16%
• Lipid 16%
• Diet 16%
• Signal Transduction 16%
• Quality of Life 16%
• Environmental Factor 16%
• Cytokine 16%
• Ligand 16%
• Lymphocyte 16%
• Receptor Antagonist 16%
• Ulcerative Colitis 16%
• Crohn's Disease 16%
• Membrane 16%
• Illness 16%
• Blood Cell 16%
• Sphingosine Kinase 16%
• Sphingosine 1 Phosphate Receptor 16%
• Guanine Nucleotide Binding Protein 16%
• Cytokine Signaling 16%
• Antiinflammatory Agent 16%
• Sphingolipid Signaling 16%

Biochemistry, Genetics and Molecular Biology

• Mediator 100%
• Sphingolipid 100%
• Sphingosine-1-Phosphate 66%
• Tumor Necrosis Factors 33%
• Life 16%
• Electric Potential 16%
• Morbidity 16%
• Genetics 16%
• Host 16%
• Lysozyme 16%
• Proinflammatory Cytokine 16%
• Signal Transduction 16%
• Cytokine 16%
• Lymphocyte 16%
• Lifestyle 16%
• Membrane 16%
• Receptor Antagonist 16%
• Sphingosine-1-Phosphate Receptor 16%
• Sphingosine Kinase 16%
• G Protein 16%
• Bioactive Lipids 16%